This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Nestle Hikes Prices, Sees Growth Ahead

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

VEVEY, Switzerland ( TheStreet) -- Nestle (NSRGY) had an admittedly "tough" first half as higher costs and a stronger Swiss franc pressured results and offset price increases, but the world's biggest food company sees growth ahead, particularly in emerging markets.

Nestle's Kit-Kat bars.

Nestle said it expects full-year sales to grow at the high end of its 5% to 6% forecast, and that margins in constant currencies would widen. A strong Swiss franc -- the currency in which Nestle reports its results -- cut first-half revenue by 13.8%.

Strong sales, particularly in emerging markets, helped the maker of Kit Kat, Carnation and Nescafe brands book 7.5% growth in first-half sales, indicating that second-half revenue will continue to face headwinds considering its full-year outlook.

Volatile costs for ingredients and raw materials represent some of those headwinds, along with "subdued" consumer spending in developed markets and economic instability on a global scale.

Passing higher costs for things like sugar, cocoa and coffee onto consumers can only help so much. Nestle raised prices on many of its products in the second quarter, even more so than it had in the first, just as fellow multinationals Kraft Foods (KFT) and Uniliver (UN) did.

"Investing in our business, both organically and through bolt-on buys, and increasing our dividend is our priority," said CFO James Singh, commenting that acquisition opportunities would be considered around the world.

Singh's comments, and Nestle's word that it would not initiate a new share- buyback program, stoked rumors that Nestle might consider acquiring Pfizer's (PFE - Get Report) nutrition business, a unit the pharmaceutical company said in July it was looking to unload.

Nestle's net earnings in the first-half fell 12.7% year over year to 4.7 billion francs ($6.33 billion). Excluding the impact of the divestiture of its Alcon eyecare business, profit was flat.

American depositary receipts of Nestle fell 2.3% to $62.42 in morning trading in New York as the major stock indexes tumbled nearly 4% after the Federal Reserve vowed to keep interest rates near zero for at least two more years.

-- Written by Miriam Marcus Reimer in New York.

>To contact the writer of this article, click here: Miriam Reimer.

>To follow the writer on Twitter, go to
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
PFE $32.56 -1.00%
UN $43.83 -1.50%
UL $44.64 -1.10%
AAPL $93.21 -1.70%
FB $116.65 -0.07%


Chart of I:DJI
DOW 17,692.18 -138.58 -0.78%
S&P 500 2,054.18 -21.63 -1.04%
NASDAQ 4,754.7040 -50.5870 -1.05%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs